Quarterly and annual results disclosed under 8-K Item 2.02.
Janux Therapeutics, Inc. reported the quarter ended March 31, 2026 results: net income Net loss was $24.4 million for the quarter ended March 31, 2026.
“Janux Therapeutics, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2026.”
SkinHealth Systems Inc. updated its first quarter ended March 31, 2026 guidance (lowered).
“On May 7, 2026, SkinHealth Systems Inc. (the “Company”) issued a press release and will hold a conference call regarding its financial results for its fiscal quarter ended March 31, 2026.”
Nerdy Inc. reported first quarter ended March 31, 2026 results: revenue $48.7 million.
“In the first quarter of 2026, we beat the top end of our revenue guidance, delivered our second consecutive quarter of positive non-GAAP adjusted EBITDA, and translated the AI-native foundation we finished building at the end of 2025 into shipped, learner-facing product at a cadence we have never matched in this company’s history. Revenue was $48.7 million, above the top end of our $46 to $48 million guidance range and up 2% year-over-year.”
ESS Tech, Inc. reported first quarter ended March 31, 2026 results: revenue $128 thousand, net income $(15.9) million, EPS $(0.54) per share.
“the Company continued its leadership and organizational reset focused on governance, execution, and financial discipline. First Quarter 2026 Financial Highlights • Revenue was $128 thousand for the three months ended March 31, 2026, compared with $0.6 million in the prior-year period due to fewer deliveries of equipment to customers. • Total operating expenses”
GCM Grosvenor Inc. reported financial results for Q1 2026.
“On May 7, 2026 , GCM Grosvenor Inc. (the “Company”) reported financial results for the three months ended March 31, 2026.”
Rocket Lab Corp updated its the first quarter ended March 31, 2026 guidance (reaffirmed).
“On May 7, 2026, Rocket Lab Corporation (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2026.”
Grindr Inc. reported the first quarter ended March 31, 2026 results: revenue $130 Million, net income $27 Million. Guidance raised.
“Grindr Inc. Reports First Quarter 2026 Revenue Growth of 38%, Raises Guidance First Quarter 2026 Revenue of $130 Million Net Income of $27 Million, Net Income Margin of 21% Adjusted EBITDA of $58 Million and Adjusted EBITDA Margin of 45% Increasing expectation of full-year 2026 Revenue of at least $535 Million and Adjusted EBITDA of at least $227 Million”
Affirm Holdings, Inc. reported financial results for third fiscal quarter ended March 31, 2026.
“On May 7, 2026, the Company issued a Shareholder Letter (the “Letter”) regarding its financial results for the third fiscal quarter ended March 31, 2026.”
Foghorn Therapeutics Inc. reported financial results for the quarter ended March 31, 2026.
“On May 7, 2026, Foghorn Therapeutics Inc. (the “Company”) issued a press release announcing certain of the Company’s financial results for the quarter ended March 31, 2026.”
Advanced Flower Capital Inc. reported the quarter ended March 31, 2026 results: net income $4.8 million, EPS $0.21 per basic weighted average share.
“GAAP net investment income (“NII”) for the quarter ended March 31, 2026, was $4.8 million, or $0.21 per basic weighted average share”
NUSCALE POWER Corp reported financial results for the first quarter which ended March 31, 2026.
“On May 7, 2026, NuScale Power Corporation announced its financial results for the first quarter which ended March 31, 2026. A copy of the press release making this announcement is attached hereto as Exhibit 99.1.”
GPGI, Inc. reported financial results for the three months ended March 31, 2026.
“On May 7 , 2026, GPGI, Inc. (the “Company”) issued a press release announcing its financial results for the three m onths ended March 31, 2026, and provided an investor presentation to accompany the press release.”
MARAVAI LIFESCIENCES HOLDINGS, INC. reported first quarter ended March 31, 2026 results: revenue $65.8 million, net income $(6.4) million. Guidance raised.
“Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2026, together with other business updates. Key Financial Results: • Revenue of $65.8 million, Net loss of $(6.4) million, and Adjusted EBITDA of $20.3 million;”
FiscalNote Holdings, Inc. reported the first quarter ended March 31, 2026 results: revenue $20.0 million, net income $(43.6). Guidance reaffirmed.
“leader in AI-driven policy and regulatory intelligence, today reported financial results for the first quarter ended March 31, 2026. The Company reported Q1 2026 revenues of $20.0 million and Adjusted EBITDA (1) of $1.0 million, both meeting guidance. Customer engagement and retention metrics for PolicyNote continue to exceed the Company’s legacy platforms,”
ARKO Corp. reported first quarter ended March 31, 2026 results: net income Net loss for the quarter was $5.6 million.
“Net loss for the quarter was $5.6 million compared to a net loss of $12.7 million.”
Monte Rosa Therapeutics, Inc. reported financial results for the quarter ended March 31, 2026.
“On May 7, 2026, Monte Rosa Therapeutics, Inc. (the "Company") announced its financial results for the quarter ended March 31, 2026.”
Ginkgo Bioworks Holdings, Inc. reported the first quarter ended March 31, 2026 results: revenue $19 million, net income $(76) million. Guidance reaffirmed.
“• First quarter 2026 Revenue of $19 million compared to $38 million in the comparable prior year period, a decrease of 49%. As previously reported, the first quarter of 2025 benefited from $7 million of non-cash revenue from previously announced release of deferred revenue relating to the mutual termination of a customer agreement. Excluding this non-cash deferred revenue release, first quarter 2026 Revenue of $19 million, down from $31 million in the comparable prior year period, a decrease of 37%. The decrease in revenue is primarily attributed to ongoing program rationalization as part of our restructuring activities. • First quarter 2026 GAAP net loss from continuing operations of $(76) million, compared to $(83) million in the comparable prior year period.”
Vera Therapeutics, Inc. reported first quarter ended March 31, 2026 results: net income a net loss of $121.0 million, EPS a net loss per diluted share of $1.69.
“For the quarter ended March 31, 2026, Vera Therapeutics reported a net loss of $121.0 million, or a net loss per diluted share of $1.69”
Cytek Biosciences, Inc. reported first quarter ended March 31, 2026 results: revenue $44.1 million, net income Net loss in the first quarter of 2026 was $18.9 million. Guidance reaffirmed.
“cell analysis solutions company, today reported financial results for the first quarter ended March 31, 2026. Recent Highlights • Total revenue for the first quarter of 2026 was $44.1 million, representing a 6% increase compared to the first quarter of 2025 • Service revenue for the first quarter of 2026 was $15.4 million, representing a 15% increase compared to”
Serve Robotics Inc. /DE/ reported the first quarter ended March 31, 2026 results: revenue $3.0 million. Guidance reaffirmed.
“on Form 8-K. --- EX-99.1 (EX-99.1) --- Serve Robotics Announces First Quarter 2026 Results with 3X Sequential Revenue Growth • Revenue scaled ahead of plan; Q1 revenue of $3.0 million, up 238% sequentially and 578% year over year, reflecting growth across all offerings. • Entered into additional vertical through acquisition of Diligent Robotics; expanding”
N-able, Inc. reported first quarter ended March 31, 2026 results: revenue $133.7 million, net income $(0.6) million, or $0.00 per diluted share, EPS $0.00 per diluted share.
“O’Brien. “As we look ahead, we remain focused on strong execution while driving a balanced mix of growth and profit.” First quarter 2026 financial highlights: • Total revenue of $133.7 million, representing 13.1% year-over-year growth, or 8.3% year-over-year growth on a constant currency basis. • Subscription revenue of $132.5 million, representing 13.4% year-over-year”
ImageneBio, Inc. reported financial results for quarter ended March 31, 2026.
“On May 7, 2026, ImageneBio, Inc. (the “Company”) announced its financial results for the quarter ended March 31, 2026.”
Better Home & Finance Holding Co reported Q2 2026 results: revenue Total Net Revenues of $53.0 to $56.0 million. Guidance initiated.
“Provided guidance of Loan Volume of $1.575 to $1.725 billion, Total Net Revenues of $53.0 to $56.0 million, and Adjusted EBITDA of ($12.5) to ($14.0) million in Q2 2026.”
Better Home & Finance Holding Co reported Q1 2026 results: revenue Total Net Revenues of $48 million, net income Net Loss of $70 million.
“Total Net Revenues of $48 million, compared to $31 million in Q1 2025, reflecting 52% growth year over year. • Net Loss of $70 million, compared to a loss of $51 million in Q1 2025 reflecting a 39% increase year over year.”
BKV Corp reported first quarter of 2026 results: net income $44.1 million, EPS $0.42 per diluted share.
“Net income attributable to BKV of $44.1 million or $0.42 per diluted share”
SOUNDHOUND AI, INC. reported first quarter 2026 results: revenue $44.2 million, net income $(25.0) million, EPS $(0.06).
“loss and condensed consolidated statements of cash flows for the period ended March 31, 2026 . --- EX-99.1 (EX-99.1) --- SoundHound AI Reports Record Q1 Revenue of $44.2 million, Up 52% Launches OASYS as the gold standard agentic platform to revolutionize the way businesses interact with customers across every channel and touchpoint SANTA CLARA,”
Grove Collaborative Holdings, Inc. reported first quarter ended March 31, 2026 results: revenue $36.2 million, net income Net Loss was $1.0 million. Guidance raised.
“Benefit Corporation, today reported financial results for its fiscal first quarter ended March 31, 2026. Key First Quarter 2026 Financial Highlights: ● Total Net Revenue was $36.2 million, down 16.8% year-over-year ● Adjusted EBITDA was positive $0.3 million, compared to a loss of $1.6 million in the same period last year ● Net Loss was $1.0 million, compared to a”
indie Semiconductor, Inc. reported first quarter ended March 31, 2026 results: revenue $55.5M, EPS loss per share was $0.21.
“set forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 indie Reports First Quarter 2026 Results • Delivered Q1 2026 Revenue of $55.5M, exceeding the midpoint of the outlook, up 3% year-over-year • Received $25M production order for radar chipset from Tier 1 partner driven by two OEM customers ALISO VIEJO,”
LifeStance Health Group, Inc. reported the first quarter ended March 31, 2026 results: revenue $403.5 million, net income $14.2 million. Guidance raised.
“for the first quarter ended March 31, 2026. (All results compared to prior-year comparative period, unless otherwise noted) 2026 Highlights and FY 2026 Outlook • Revenue of $403.5 million increased 21% compared to revenue of $333.0 million • Clinician base increased 11% to 8,349 clinicians, a sequential net increase of 309 in the first quarter • First quarter”
Payoneer Global Inc. updated its the fiscal quarter ended March 31, 2026 guidance (raised).
“On May 7, 2026, Payoneer Global Inc. issued a press release announcing its financial results for the fiscal quarter ended March 31, 2026.”
OmniAb, Inc. reported the three months ended March 31, 2026 results: revenue $14.4 million. Guidance raised.
“as demonstrated by the launch of OmniUltra TM and our xPloration ® partner access program. ” First Quarter 2026 Financial Results Revenue for the first quarter of 2026 was $14.4 million , compared with $4.2 million for the same period in 2025 , with the increase primarily related to milestone revenue . Research and development expense was $9.6 million for the”
FIGS, Inc. reported Full Year 2026 results: revenue Net Revenues growth vs. 2025 up 14% to 16%. Guidance raised.
“Full Year 2026 Financial Outlook Net Revenues growth vs. 2025 up 14% to 16% Adjusted EBITDA Margin (2)(4) 13.0% to 13.2% Sarah Oughtred, Chief Financial Officer, commented, “Our strong start to 2026 fuels our confidence and supports higher net revenues and adjusted EBITDA margin expectations for the rest of the year.”
FIGS, Inc. reported First Quarter 2026 results: revenue Net revenues were $159.9 million, net income Net income was $6.3 million, EPS $0.03 in diluted earnings per share. Guidance raised.
“financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. First Quarter 2026 Financial Highlights • Net revenues were $159.9 million, an increase of 28.0% year over year, primarily due to an increase in orders from new and existing customers and higher average order value (“AOV”). (1) • Scrubwear net revenues”
PSQ Holdings, Inc. reported first quarter 2026 results: revenue $8.2 million, net income $6.5 million, EPS $0.12.
“FIRST QUARTER 2026 HIGHLIGHTS · Net revenue from continuing operations, which includes the financial technology (“fintech”) segment, for the quarter ended March 31, 2026 was $8.2 million compared to $3.1 million for the first quarter ended March 31, 2025, a 167% increase compared to the prior year period. · Operating expense (defined as general and”
Kodiak AI, Inc. reported the three months ended March 31, 2026 results: revenue $1.8 million.
“to 86% as of the end of April • Announced plans to integrate the NVIDIA DRIVE Hyperion architecture in the next-generation of Kodiak Driver-powered trucks • Q1 Revenue of $1.8 million, representing 74% growth quarter-over-quarter • Q1 Net cash used in operating activities of $29.5 million • Q1 Free Cash Flow (Non-GAAP) of negative $35.0 million • Ended Q1 with”
EverCommerce Inc. reported the quarter ended March 31, 2026 results: revenue $147.5 million, net income $7.2 million, EPS $0.04 per basic and diluted share.
“commerce platform, today announced financial results for the quarter ended March 31, 2026. First Quarter 2026 Financial Highlights • Revenue from continuing operations of $147.5 million, an increase of 3.6% compared to $142.3 million for the quarter ended March 31, 2025. Pro Forma Revenue increased 3.0% to $147.5 million, compared to $143.2 million for the”
Zura Bio Ltd reported first quarter ended March 31, 2026 results: net income $24.2 million, or $0.22 per share, EPS $0.22 per share.
“Net loss for the first quarter of 2026 was $24.2 million, or $0.22 per share”
Blend Labs, Inc. reported the second quarter of 2026 results: revenue $32.0M - $34.0M. Guidance initiated.
“Second Quarter Outlook Blend is providing guidance for the second quarter of 2026 as follows: $ in millions Q2 2026 Guidance Total Revenue $32.0M - $34.0M Non-GAAP Operating Income $5.5M - $6.5M”
Blend Labs, Inc. reported the fiscal quarter ended March 31, 2026 results: revenue $30.8 million, EPS $0.04.
“Repurchased 11.2 million shares in the first quarter for $18.6 million — $31.4 million remaining on the existing authorization at quarter end. First quarter revenue was $30.8 million, an increase of 15% compared to the first quarter of 2025. Software platform revenue was $28.0 million, up 15% year-over-year, and Professional services revenue was $2.9 million”
Krispy Kreme, Inc. updated its first quarter ended March 29, 2026 guidance (reaffirmed).
“On May 7, 2026, the Company issued a press release announcing the Company's financial results for the first quarter ended March 29, 2026.”
GigaCloud Technology Inc reported second quarter of 2026 results: revenue $365 million and $390 million. Guidance initiated.
“The Company expects its total revenues to be betwe en $365 million and $390 million in t he second quarter of 2026.”
GigaCloud Technology Inc reported first quarter ended March 31, 2026 results: revenue $359.5 million, net income $38.1 million, EPS $1.04.
“Total revenues of $359.5 million, increased 32.2% year-over-year. • Gross profit of $85.8 million, increased 34.7% year-over-year. Gross margin was 23.9%, compared to 23.4% in the first quarter of 2025. • Net income of $38.1 million, compared to $27.1 million reported in the prior-year period. Net income margin was 10.6%, compared to 10.0% in the first quarter of 2025. Diluted EPS increased 52.9% year-over-year to $1.04.”
Nuvalent, Inc. reported financial results for first quarter 2026.
“Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today outlined pipeline progress, reiterated key anticipated milestones, and reported first quarter 2026 financial results.”
Definitive Healthcare Corp. reported Q1 2026 results: revenue $55.9 million, net income $(192.4) million.
“First Quarter 2026 Financial Highlights: • Revenue was $55.9 million, a decrease of 6% from $59.2 million in Q1 2025. • Net Loss , inclusive of goodwill impairment charges of $197.2 million, was $(192.4) million, or (344)% of revenue, compared to $(155.1) million in Q1 2025, inclusive of goodwill impairment charges of $176.5 million, or (262)% of revenue.”
Clearwater Analytics Holdings, Inc. reported the first quarter ended March 31, 2026 results: revenue $221.2 million, net income $2.8 million, EPS $0.01.
“measures is contained in the attached press release. --- EX-99.1 (EX-99.1) --- Clearwater Analytics Announces First Quarter 2026 Financial Results Quarterly Revenue of $221.2 Million, Up 74% Year-Over-Year Annualized Recurring Revenue of $872 Million, Up 77% Year-Over-Year Adjusted EBITDA of $77.4 Million, Up 72% Year-Over-Year BOISE, Idaho — May 7, 2026 —”
Consensus Cloud Solutions, Inc. reported first quarter of fiscal 2026 results: revenue $88.5 million, net income $24.7 million, EPS $1.30. Guidance reaffirmed.
“operating activities and Free cash flow.” said Scott Turicchi, CEO of Consensus. FIRST QUARTER UNAUDITED 2026 HIGHLIGHTS Q1 2026 quarterly revenues increased by $1.3 million to $88.5 million compared to $87.1 million for Q1 2025. This increase was primarily due to an increase of $4.4 million or 8.2% in our Corporate business, partially offset by a decrease of $3.1”
Xeris Biopharma Holdings, Inc. reported the three months ended March 31, 2026 results: revenue $83,127, net income $2.2 million.
“Three months ended March 31, Change 2026 2025 $ % Product revenue (in thousands): Recorlev $ 49,768 $ 25,530 $ 24,238 95 Gvoke 20,800 20,845 (45) — Keveyis 11,886 11,427 459 4 Product revenue, net 82,454 57,802 24,652 43 Royalty, contract and other revenue 673 2,317 (1,644) (71) Total revenue $ 83,127 $ 60,119 $ 23,008 38”
Chicago Atlantic Real Estate Finance, Inc. reported first quarter ended March 31, 2026 results: net income Net income $ 4,840,364 $ 0.23, EPS Distributable earnings - diluted $ 9,833,020 $ 0.46.
“$ 0.61 $ 14,238,203 $ 0.66 $ 13,041,933 $ 0.61 Total expenses before provision for expected credit losses $ 4,239,871 $ 0.20 $ 5,981,137 $ 0.28 $ 4,073,897 $ 0.19 Net income $ 4,840,364 $ 0.23 $ 8,157,249 $ 0.38 $ 10,041,312 $ 0.47 (Benefit) provision for current expected credit losses $ 3,837,851 $ 0.18 $ 99,817 $ 0.00 $ (1,073,276 ) $ (0.05 ) Distributable”
Orion Properties Inc. reported the first quarter ended March 31, 2026 results: revenue $36.3 million, net income $(13.6) million, or $(0.24) per share.
“First Quarter 2026 Financial Overview • Total revenues of $36.3 million • Net loss attributable to common stockholders of $(13.6) million, or $(0.24) per share”
Arhaus, Inc. reported the first quarter ended March 31, 2026 results: revenue $314 million, net income decreased 54.5% to $2 million. Guidance reaffirmed.
“design, reported first quarter results for the period ended March 31, 2026. First Quarter 2026 Highlights Compared to the first quarter of 2025: • Net revenue increased 0.9% to $314 million • Gross margin decreased 1.0% to $114 million • Selling, general and administrative expenses increased 1.9% to $112 million • Net and comprehensive income decreased 54.5% to $2”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.